Alan Montgomery is a Partner at the London office of a leading international law firm, serving as Co-Head of both the Pharmaceuticals sector and the India practice. He specialises in public and private cross-border mergers and acquisitions, restructurings, joint ventures, and partnership matters, advising international corporates, investment banks, and professional services firms.

Alan has led numerous high-profile transactions, including Lupin’s US$600 million disposal of Kyowa Pharmaceutical, Bharti Airtel’s US$10.7 billion acquisition of Zain Africa, and Claris Life Sciences’ US$625 million sale of its Global Generic Injectables Business to Baxter. His expertise spans pharmaceuticals, healthcare, oil and gas, mining, and water and waste sectors, providing comprehensive corporate, M&A, public M&A, joint ventures, and restructuring advice.

Recognised as a top-tier M&A lawyer in London and a leading international lawyer for India-related transactions, Alan is praised for his thorough research, strategic thinking, and confident negotiation style. Clients and industry directories commend his ability to handle complex matters with clarity and efficiency. He is described as dependable, hard-working, and responsive, delivering outstanding results across challenging deals.

Alan’s extensive experience and leadership make him a trusted advisor for clients navigating complex cross-border transactions in dynamic global markets.